Mobidiag

Mobidiag

Mobidiag

Offering fast and reliable in vitro diagnostics for infectious diseases
Type
B2b
Founded
2000
Raised
$44.9M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$1,500,000
Undisclosed - 2020
€10,000,000
Venture capital - 2019
Team Size
100+
Employees
Location
Headquarters

Product overview

the problem

Need for fast and reliable diagnostics for infectious diseases to drive treatment and infection control

the solution

Molecular diagnostics tests based on multiplex real-time PCR and compatible systems for rapid, reliable and cost-efficient detection of infectious disesases

target group

Hospitals, clinical laboratories, microbiology laboratories (bacteriology, virology, parasitology, etc.)

$1,500,000 Undisclosed
FinSMEs

Mobidiag Raises EUR 1.5M In Additional Funding

€10,000,000 Venture capital
FinSMEs

Mobidiag Receives €10M Equity Investment

€4,000,000 Debt financing
FinSMEs

Mobidiag Receives Final €4M Tranche of €15M EIB Financing

€1,500,000 Debt financing
FinSMEs

Molecular Diagnostics Company Mobidiag Raises €1.5M Loan

Health Funding Global
€4,000,000 Venture capital
FinSMEs

Mobidiag Secures Additional €4M in Funding

Health Funding
€3,990,000 Debt financing
Tech.eu

Finnish Mobidiag raises €3.99 million to improve detection of infectious diseases

$16,500,000 Debt financing
FierceBiotech

Finnish molecular diagnostics maker gets €15M for infectious disease test development

Health Apps & Services